0069-1975Level 3
Vyndaqel (tafamidis meglumine)
**Product type:** Human Prescription Drug
**Active ingredient:** TAFAMIDIS MEGLUMINE
**Strength:** 20 mg/1
**Dosage form:** Capsule, Liquid Filled
**Route:** Oral
**Labeler:** Pfizer Laboratories Div Pfizer Inc
**Marketing category:** NDA (NDA211996)
GET
/api/v1/systems/ndc_fda/nodes/0069-1975Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.